Stephens Consulting’s Select Medical SEM Stock Holding History

Stephens Consulting’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50	Closed	-$835	–	1859
2025 Q1	$835	Buy	+50	New	+$920	﹤0.01%	733

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

8KM

8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Stephens Consulting's SEM Position: Q2 2025 in Review

Stephens Consulting sold out of Select Medical (SEM) in Q2 2025, closing a stake of 50 shares — an estimated $835 sold.

Stephens Consulting first reported a position in SEM in Q1 2025 and held it in 1 quarter. The position peaked at $835 in Q1 2025. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

Stephens Consulting reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 50 Select Medical shares in Q2 2025, an estimated $835.
Stephens Consulting first reported a position in Select Medical in Q1 2025 and held it in 1 quarter.
Stephens Consulting's Select Medical position peaked at $835 in Q1 2025.
262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.